T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $883B
1-Year Return 25.8%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Quarter Return
-6.56%
1 Year Return
+25.8%
3 Year Return
+128.18%
5 Year Return
+198.37%
10 Year Return
+601.91%
AUM
$992B
AUM Growth
-$120B
Cap. Flow
-$14.7B
Cap. Flow %
-1.48%
Top 10 Hldgs %
27.94%
Holding
3,078
New
101
Increased
1,637
Reduced
1,059
Closed
104

Top Buys

1
TSLA icon
Tesla
TSLA
$5.14B
2
JPM icon
JPMorgan Chase
JPM
$2.05B
3
TEAM icon
Atlassian
TEAM
$2.04B
4
NVDA icon
NVIDIA
NVDA
$1.97B
5
AAPL icon
Apple
AAPL
$1.73B

Sector Composition

1 Technology 26.88%
2 Healthcare 17.2%
3 Consumer Discretionary 15.14%
4 Financials 10.69%
5 Communication Services 10.4%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
EMAN
2926
DELISTED
eMagin Corporation
EMAN
$31K ﹤0.01%
27,300
LPTH icon
2927
Lightpath Technologies
LPTH
$229M
$30K ﹤0.01%
15,300
AUD
2928
DELISTED
Audacy, Inc.
AUD
$30K ﹤0.01%
+10,513
New +$30K
SVRA icon
2929
Savara
SVRA
$665M
$29K ﹤0.01%
21,860
+4,600
+27% +$6.1K
CBUS icon
2930
Cibus
CBUS
$68.3M
$29K ﹤0.01%
562
RLX icon
2931
RLX Technology
RLX
$3.29B
$28K ﹤0.01%
15,500
URG
2932
Ur-Energy
URG
$536M
$26K ﹤0.01%
16,485
+4,500
+38% +$7.1K
CRBP icon
2933
Corbus Pharmaceuticals
CRBP
$121M
$25K ﹤0.01%
1,547
+553
+56% +$8.94K
RNAC icon
2934
Cartesian Therapeutics
RNAC
$265M
$21K ﹤0.01%
578
+113
+24% +$4.11K
VSTM icon
2935
Verastem
VSTM
$630M
$21K ﹤0.01%
1,260
+308
+32% +$5.13K
HAACW
2936
DELISTED
Health Assurance Acquisition Corp. Warrants
HAACW
$18K ﹤0.01%
35,000
BOAC.WS
2937
DELISTED
Bluescape Opportunities Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
BOAC.WS
$16K ﹤0.01%
46,500
GOCO icon
2938
GoHealth
GOCO
$76.3M
$14K ﹤0.01%
775
-13,418
-95% -$242K
ONYXW
2939
DELISTED
Onyx Acquisition Co. I Warrant
ONYXW
$13K ﹤0.01%
+37,750
New +$13K
NMTR
2940
DELISTED
9 Meters Biopharma, Inc. Common Stock
NMTR
$12K ﹤0.01%
990
+274
+38% +$3.32K
GVCIW
2941
DELISTED
Green Visor Financial Technology Acquisition Corp. I Warrants
GVCIW
$12K ﹤0.01%
+37,925
New +$12K
TNXP icon
2942
Tonix Pharmaceuticals
TNXP
$222M
0
-$10K
AFACW
2943
DELISTED
Arena Fortify Acquisition Corp. Warrant
AFACW
$9K ﹤0.01%
+37,500
New +$9K
TRVN
2944
DELISTED
Trevena, Inc.
TRVN
$8K ﹤0.01%
23
+7
+44% +$2.44K
PRPC.WS
2945
DELISTED
CC Neuberger Principal Holdings III Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
PRPC.WS
$8K ﹤0.01%
12,125
MLAIW
2946
DELISTED
McLaren Technology Acquisition Corp. Warrant
MLAIW
$8K ﹤0.01%
+37,750
New +$8K
NBEV
2947
DELISTED
NewAge, Inc. Common Stock (Delaware)
NBEV
$7K ﹤0.01%
+12,443
New +$7K
MEIP icon
2948
MEI Pharma
MEIP
$98.2M
$6K ﹤0.01%
+516
New +$6K
EUCRW
2949
DELISTED
Eucrates Biomedical Acquisition Corp. Warrant
EUCRW
$4K ﹤0.01%
22,697
STAB
2950
DELISTED
Statera Biopharma, Inc. Common Stock
STAB
$4K ﹤0.01%
+11,700
New +$4K